I'm not comparing Phase II and Phase III results. Go back to ALS drug candidates that failed Phase III studies (last 5 years) and look at their Phase II studies. You will realize their Phase II studies where vastly stronger than CYTK's (patient self-assessment) study. I'd give you the names of these drugs however why do everything for you. Its about time this board did some real homework.